ACCESSION: MSBNK-SMB_Measured-HSA014P0240000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'EL06-neg_1877': {'bp': 646523.0, 'sum': 852154.0}, 'EL02-neg_1880': {'bp': 645509.0, 'sum': 839738.0}, 'EL03-neg_1881': {'bp': 535438.0, 'sum': 705151.0}, 'EL08-neg_1869': {'bp': 507511.0, 'sum': 670681.0}, 'EL18-neg_1873': {'bp': 494752.0, 'sum': 653817.0}, 'EL01-neg_1882': {'bp': 483572.0, 'sum': 656444.0}, 'EL05-neg_1886': {'bp': 465758.0, 'sum': 632309.0}, 'EL20-neg_1887': {'bp': 459633.0, 'sum': 604399.0}, 'EL09-neg_1884': {'bp': 448973.0, 'sum': 603548.0}, 'EL16-neg_1873': {'bp': 427307.0, 'sum': 569330.0}, 'EL04-neg_1881': {'bp': 368110.0, 'sum': 494744.0}, 'EL14-neg_1873': {'bp': 363781.0, 'sum': 483240.0}}
COMMENT: RETENTION_TIME_STDEV 0.008
COMMENT: PRECURSOR_M/Z_RAW 240.051055
COMMENT: PRECURSOR_M/Z_STDEV 0.000093
COMMENT: PRECURSOR_IN_MS1 mz 240.051376; int 20.876; delta(ppm) 1.021302
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.058; C10H11NO6; [M-H]1; delta(ppm) 0.058077
COMMENT: PROPOSED_MF SevenGoldenRules 4.343; C4H12N5O5P; [M-H]1; delta(ppm) 4.343341
COMMENT: PROPOSED_MF MS-FINDER 3.600; C10H11NO6; [M-H]-; delta(ppm) 0.059744
COMMENT: PROPOSED_MF MS-FINDER 2.374; C11H15NOS2; [M-H]-; delta(ppm) -3.560375
COMMENT: PROPOSED_MF MS-FINDER 2.343; C4H12N5O5P; [M-H]-; delta(ppm) 4.365343
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.067; C10H11NO6; [M-H]-; delta(ppm) 0.059744
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.518; C11H12FNO2S; [M-H]-; delta(ppm) 5.722965
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H11NO6; [M-H]-; delta(ppm) 0.059744
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.437; C10H11NO6; [M-H]-; delta(ppm) 0.059744
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.119; C7H12FNO7; [M-H]-; delta(ppm) -4.700273
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.195; C8H13F2NO3S; [M-H]-; delta(ppm) 0.962894
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.036; C11H7N5O2; [M-H]-; delta(ppm) -5.511591
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.685; C8H9N4O5; [M-H]-; delta(ppm) 5.653010
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.061; C9H15NO3Si2; [M-H]-; delta(ppm) -210346.707905
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.869; C6H7F4N5O; [M-H]-; delta(ppm) -0.085192
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.518; C5H12ClN5O4; [M-H]-; delta(ppm) -90888.409521
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.068; C7H13F2NO4Si; [M-H]-; delta(ppm) -210344.480626
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.745; C4H12N5O5P; [M-H]-; delta(ppm) 4.365343
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.991; C10H11NO6; [M-H]-; delta(ppm) 0.059744
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C7H12FNO7; [M-H]-; delta(ppm) -4.700273
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C8H13F2NO3S; [M-H]-; delta(ppm) 0.962894
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C9H15NO3Si2; [M-H]-; delta(ppm) -210346.707905
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.613; PWWNTPFXJSBHQK-UHFFFAOYNA-N; [M-H]-; CC(=O)CC1(O)C2OC2C(=O)C(C(O)=O)=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.611; VKKYJXLQEGBUNY-KADJCCMJSA-N; [M-H]-; CC(=O)C[C@@]1([C@@H]2[C@@H](O2)C(=C(C1=N)C(=O)O)O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.454; VBXNJRCPOOQJML-UHFFFAOYNA-N; [M-H]-; COC1=C(OC)C2=C(C=C1)N(O)C(=O)C(O)O2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.440; VVCAIBZWJDJGJQ-UHFFFAOYNA-N; [M-H]-; COC1=C(OC)C=C2N(O)C(=O)C(O)OC2=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.333; UKFFJSITCNRUQV-UHFFFAOYSA-N; [M-H]-; COC1=CC(=CC(O)=C1O)C(O)=NCC(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.753; VDTYHTVHFIIEIL-MDOHGIEYNA-N; [M-H]-; N-(2,3-dihydroxybenzoyl)-L-serine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.655; VBXNJRCPOOQJML-UHFFFAOYNA-N; [M-H]-; 2,4-Dihydroxy-7,8-dimethoxy-2H-1,4-benzoxazin-3(4H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.601; VVCAIBZWJDJGJQ-UHFFFAOYNA-N; [M-H]-; 2,4-Dihydroxy-6,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.589; PWWNTPFXJSBHQK-UHFFFAOYNA-N; [M-H]-; Enaminomycin B;2-oxo-4-amino-5-hydroxy-5-acetonyl-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.542; VKKYJXLQEGBUNY-KADJCCMJSA-N; [M-H]-; Enaminomycin B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.538; BMDINQDTXHYJDR-IMWMWJONNA-N; [M-H]-; UNPD168514
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.538; YUPKNIBMTXNJKR-UHFFFAOYSA-N; [M-H]-; 2-Hydroxy-3-(4-hydroxy-3-nitrophenyl)-propionic acid methyl ester
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.494; WJPMJFUEMVXUCV-UHFFFAOYSA-N; [M-H]-; CNP0447707
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.492; AZFDKRSNEAHVSP-UHFFFAOYSA-N; [M-H]-; 2-{[(2,4-dihydroxy-5-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.492; MVRBXZXPEVNSBF-UHFFFAOYSA-N; [M-H]-; 2-{[(2,4-dihydroxy-3-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.492; UKFFJSITCNRUQV-UHFFFAOYSA-N; [M-H]-; 2-{[(3,4-dihydroxy-5-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.458; LCNHYERWMDLZEM-UHFFFAOYSA-N; [M-H]-; methyl 2-[(5-methoxy-4-oxo-4H-pyran-2-yl)formamido]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LCNHYERWMDLZEM-UHFFFAOYSA-N; [M-H]-; methyl 2-[(5-methoxy-4-oxo-4H-pyran-2-yl)formamido]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.995; PWWNTPFXJSBHQK-UHFFFAOYNA-N; [M-H]-; Enaminomycin B;2-oxo-4-amino-5-hydroxy-5-acetonyl-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; VKKYJXLQEGBUNY-KADJCCMJSA-N; [M-H]-; Enaminomycin B
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; AZFDKRSNEAHVSP-UHFFFAOYSA-N; [M-H]-; 2-{[(2,4-dihydroxy-5-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; UKFFJSITCNRUQV-UHFFFAOYSA-N; [M-H]-; 2-{[(3,4-dihydroxy-5-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.849; MVRBXZXPEVNSBF-UHFFFAOYSA-N; [M-H]-; 2-{[(2,4-dihydroxy-3-methoxyphenyl)(hydroxy)methylidene]amino}acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.832; VDTYHTVHFIIEIL-MDOHGIEYNA-N; [M-H]-; N-(2,3-dihydroxybenzoyl)-L-serine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.817; YUPKNIBMTXNJKR-UHFFFAOYSA-N; [M-H]-; 2-Hydroxy-3-(4-hydroxy-3-nitrophenyl)-propionic acid methyl ester
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; BMDINQDTXHYJDR-IMWMWJONNA-N; [M-H]-; UNPD168514
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; WJPMJFUEMVXUCV-UHFFFAOYSA-N; [M-H]-; CNP0447707
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.811; VBXNJRCPOOQJML-UHFFFAOYNA-N; [M-H]-; 2,4-Dihydroxy-7,8-dimethoxy-2H-1,4-benzoxazin-3(4H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; VVCAIBZWJDJGJQ-UHFFFAOYNA-N; [M-H]-; 2,4-Dihydroxy-6,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.347; VDTYHTVHFIIEIL-LURJTMIESA-N; [M-H]-; (2S)-2-[(2,3-dihydroxybenzoyl)amino]-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.444; WJPMJFUEMVXUCV-UHFFFAOYSA-N; [M-H]-; 2-(4,5-dimethoxy-2-nitrophenyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.833; VBXNJRCPOOQJML-UHFFFAOYSA-N; [M-H]-; 2,4-dihydroxy-7,8-dimethoxy-1,4-benzoxazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.760; VVCAIBZWJDJGJQ-UHFFFAOYSA-N; [M-H]-; 2,4-dihydroxy-6,7-dimethoxy-1,4-benzoxazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.702; SYYKLKHBZGFKOC-UHFFFAOYSA-N; [M-H]-; methyl 4,5-dimethoxy-2-nitrobenzoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.576; VKKYJXLQEGBUNY-YNEQXMIYSA-N; [M-H]-; (1S,5S,6R)-2,5-dihydroxy-4-imino-5-(2-oxopropyl)-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.206; DEPIJCMSSIVPDJ-UHFFFAOYSA-N; [M-H]-; 2,3-dihydroxypropyl 3-nitrobenzoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.807; UKFFJSITCNRUQV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.490; AZFDKRSNEAHVSP; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -323.979; MVRBXZXPEVNSBF; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -343.186; VDTYHTVHFIIEIL; [M-H]-; 2,3-dihydroxybenzoylserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.554; LCNHYERWMDLZEM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.199; DEPIJCMSSIVPDJ; [M-H]-; 2,3-dihydroxypropyl 3-nitrobenzoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -363.762; SYYKLKHBZGFKOC; [M-H]-; Oprea1_288439
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.636; ZGIUTJWCSIHWGS; [M-H]-; Methyl 3,4-dimethoxynitrobenzoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -386.584; WJPMJFUEMVXUCV; [M-H]-; Oprea1_699681
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -436.684; YUPKNIBMTXNJKR; [M-H]-; methyl 2-hydroxy-3-(4-hydroxy-3-nitrophenyl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -445.614; VBXNJRCPOOQJML; [M-H]-; 2H-1,4-Benzoxazin-3(4H)-one, 2,4-dihydroxy-7,8-dimethoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -453.815; BMDINQDTXHYJDR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -462.828; VVCAIBZWJDJGJQ; [M-H]-; 2H-1,4-Benzoxazin-3(4H)-one, 2,4-dihydroxy-6,7-dimethoxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -537.033; VKKYJXLQEGBUNY; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.155; UKFFJSITCNRUQV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.750; GOSCHUJKDNCSQF; [M-H]-; 2-(Furan-2-carbonylamino)pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.707; LMZGHECZMHGXBC; [M-H]-; 2-(3-Methyl-2,5-dioxopyrrol-1-yl)pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.732; BNSVPRUOFTVCBG; [M-H]-; (2S)-2-(furan-3-carbonylamino)pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -245.295; OWOKPFCTAGAVOX; [M-H]-; (2S)-2-(2,5-dioxopyrrol-1-yl)-5-methoxy-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -255.813; ZDMTXBMWKXNYBR; [M-H]-; 2-(2,4-Dioxo-3-azabicyclo[3.1.0]hexan-3-yl)pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -266.184; DJZMDLNDLRWTAJ; [M-H]-; 4-(2,5-Dioxopyrrolidin-1-yl)oxycarbonylpent-4-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.925; KYSWLHHQEBBVFE; [M-H]-; (2S)-2-(furan-2-carbonylamino)-4-methoxy-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -284.133; NLMXADDNAVYUEP; [M-H]-; Bis(2-oxocyclopropyl) 2-aminobutanedioate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -285.237; RKSOZOKBEJBJGW; [M-H]-; 2-[[2-(Furan-2-yl)acetyl]amino]butanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -287.090; DPMISOAXSWHXTH; [M-H]-; 3-[1-(Carboxymethyl)-2-oxopyridin-3-yl]oxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.259; GOSCHUJKDNCSQF; [M-H]-; 2-(Furan-2-carbonylamino)pentanedioic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H10N1O6; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 3.209
MS$FOCUSED_ION: PRECURSOR_M/Z 240.051375
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0900000000-dd66eae9974f8e569e5b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  96.0076186 6.4376 96.007626 1.5936 1.08 0.5758 12 ?
  110.0233956 999.0000 110.023424 0.5635 0.00 0.7939 12 ?
  111.0074139 21.2529 111.007444 1.0810 3.57 0.4545 12 ?
  111.0268088 50.1804 111.026839 0.4503 3.68 0.7833 11 ?
  128.0340330 125.5869 128.034097 0.5155 3.97 0.8061 12 ?
  240.0513987 20.7603 240.051323 1.8954 2.50 1.0000 10 f{C10H10N1O6}/0.16ppm,p
PK$NUM_PEAK: 6
PK$PEAK: m/z int. rel.int.
  96.007619 6.44 6
  110.023396 999.00 999
  111.007414 21.25 21
  111.026809 50.18 50
  128.034033 125.59 125
  240.051399 20.76 20
//
